Immune Management ApS: Financial statements 2023
CVR: 38726137
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Immune Management ApS (CVR 38726137) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224. The solvency ratio was 74.1%.
- Gross Profit
- DKK -13,493
- Profit/Loss
- DKK -15,195
- Equity
- DKK 41,224
- Total Assets
- DKK 55,596
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -13K | -15K | 41K | 0 |
| 2022 | - | -13K | -17K | 71K | 0 |
| 2021 | - | -26K | -28K | 145K | 0 |
| 2020 | - | -17K | -117K | 230K | 0 |
| 2019 | - | 621K | 99K | 401K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Immune Management ApS has published its annual report for 2022. Gross profit came to DKK -13,177, and the net result was DKK -16,738.
About Immune Management ApS
Immune Management ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2017. The company has been dissolved on 2 December 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -13,493 and a net result of DKK -15,195 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK 41,224.